Data as of Jan 23
| -0.03 / -1.43%|
The 3 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 18.00 and a low estimate of 1.00. The median estimate represents a +141.55% increase from the last price of 2.07.
The current consensus among 3 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.